Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Recruiting 46Active not recruiting 28Terminated 5Completed 5Not yet recruiting 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Pancreatic Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

Specimen Handling 39Magnetic Resonance Spectroscopy 26fludarabine 17Cyclophosphamide 16Biopsy 15Paclitaxel 13Gemcitabine 13Carboplatin 13pembrolizumab 11Dexamethasone 11Radiotherapy 9Oxaliplatin 8Drug Therapy 8Cisplatin 8venetoclax 7Radiosurgery 7Nivolumab 7Interviews as Topic 7fludarabine phosphate 6cemiplimab 6Doxorubicin 6Blood Specimen Collection 6Bevacizumab 6durvalumab 5blinatumomab 5Rituximab 5Irinotecan 5Fluorouracil 5Docetaxel 5Capecitabine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Pemetrexed × 30 days × Clear all
NCT07486817 2026-05-19

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Boehringer Ingelheim

Phase 2 Not yet recruiting
60 enrolled
Thoracic

Lung Neoplasms

NCT07594626 2026-05-19

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Northwestern University

Phase 1/2 Not yet recruiting
72 enrolled
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms

NCT07586202 2026-05-14

AmiNA

Janssen Research & Development, LLC

Phase 2 Not yet recruiting
68 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07524257 2026-05-04

Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care in First-Line Advanced or Metastatic NSCLC

ImmunityBio, Inc.

Phase 3 Not yet recruiting
494 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡